| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/08/1997 | EP0751956A1 $i(PASTEURELLACEAE) ANTIGENS AND RELATED VACCINES |
| 01/08/1997 | EP0751949A1 Anti-hepatitis b viral oligonucleotides |
| 01/08/1997 | EP0751948A1 Novel phosphoramidate and phophorothioamidate oligomeric compounds |
| 01/08/1997 | EP0751947A1 Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity |
| 01/08/1997 | EP0751943A1 Triazole compounds and processes for the preparation thereof |
| 01/08/1997 | EP0751932A1 Vitamin-d amide derivatives |
| 01/08/1997 | EP0751789A1 Gel for treatment of skin diseases and for disinfection of the skin |
| 01/08/1997 | EP0751788A1 Composition including a recombinant plasmid, and uses thereof as a vaccine and drug |
| 01/08/1997 | EP0751786A1 Urease-based vaccine and treatment for helicobacter infection |
| 01/08/1997 | EP0751785A1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
| 01/08/1997 | EP0751709A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 01/08/1997 | EP0588855B1 Acylated heparins as inhibitors of the replication of retroviruses |
| 01/08/1997 | EP0558657B1 Retroviral protease inhibitors |
| 01/08/1997 | EP0471726B1 Acellular vaccine |
| 01/08/1997 | EP0469075B1 Use of lipoxin a 4? and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| 01/08/1997 | CN1139932A N-terminally chemically modified protein compositions and methods |
| 01/08/1997 | CN1139703A Polypeptide for expressing virus of pig reproduction and respiration syndrome in same cell |
| 01/08/1997 | CN1033751C Anti-bacteria optically active pyridonecarboxylic acid derivatives for treatment |
| 01/07/1997 | US5591851 Antiviral compounds |
| 01/07/1997 | US5591827 Interleukin-6 receptor antagonists |
| 01/07/1997 | US5591823 Expression of specific immunogens using viral antigens |
| 01/07/1997 | US5591770 Calanolide and related antiretroviral compounds, compositions, and uses thereof |
| 01/07/1997 | US5591744 1,4-dihydro-4-oxoquinoline-3-carboxylate derivatives; microbiocides |
| 01/07/1997 | US5591721 Orally administering oligonucleotide with phosphorothioate internucleoside linkage |
| 01/07/1997 | US5591720 Oligonucleotides for modulating the effects of cytomegalovirus infections |
| 01/07/1997 | US5591714 Derivatives of A82846 |
| 01/07/1997 | US5591600 Antisense inhibitors of the human immunodeficiency virus |
| 01/07/1997 | US5591441 Composition for nonspecific cellular immune stimulation |
| 01/07/1997 | US5591440 Hepatitis B Virus mutants, reagents and methods for detection |
| 01/07/1997 | US5591428 Intestine colonizing lactobacilli |
| 01/07/1997 | CA1338836C Endotoxin binding protein and uses thereof |
| 01/07/1997 | CA1338830C Diastereomeric 5r,6s-6-(1r-hydroxyethyl)-2-(cis-1-oxo- 3-thiolanylthio)-2-penem-3-carboxylic acids |
| 01/03/1997 | WO1997000445A1 Process for producing gm2 specific antibodies |
| 01/03/1997 | WO1997000323A1 Adenovirus e1a-associated protein bs69, inhibitor of e1a-transactivation |
| 01/03/1997 | WO1997000322A1 Immunogenic construct, process for its preparation and use as a vaccine |
| 01/03/1997 | WO1997000255A1 Tetrahydrofuran antifungals |
| 01/03/1997 | WO1997000237A1 Process for the preparation of an n-(2-bromoalkyl)-amide derivate_______________________________________________________________ |
| 01/03/1997 | WO1997000088A2 Rotavirus enterotoxin nsp4 and methods of using same |
| 01/03/1997 | WO1997000079A1 P-selectin ligands and related molecules and methods |
| 01/03/1997 | WO1997000073A1 Novel use for pyrrole derivatives |
| 01/03/1997 | CA2224707A1 Tetrahydrofuran antifungals |
| 01/03/1997 | CA2224697A1 Rotavirus enterotoxin nsp4 and methods of using same |
| 01/03/1997 | CA2224645A1 Immunogenic construct, process for its preparation and use as a vaccine |
| 01/03/1997 | CA2224625A1 P-selectin ligands and related molecules and methods |
| 01/03/1997 | CA2221027A1 Novel use for pyrrole derivatives |
| 01/02/1997 | EP0751221A1 Recombinant mistletoe lectin (rML) |
| 01/02/1997 | EP0751149A2 Phenylalanine substitution analogues of magainin peptides |
| 01/02/1997 | EP0751148A2 D-amino acid substitution analogues of Magainin peptides |
| 01/02/1997 | EP0750669A1 MODIFIED PAPILLOMA VIRUS L2 PROTEIN AND VLPs FORMED THEREFROM |
| 01/02/1997 | EP0750668A1 NOVEL MUTEINS OF IFN-$g(b) |
| 01/02/1997 | EP0750640A1 Delipidated purified polysaccharide compound d25 preparation, and injectable composition comprising same |
| 01/02/1997 | EP0750636A1 Methods to diagnose and treat hiv-1 infection |
| 01/02/1997 | EP0750632A1 Ion-channel forming amphiphilic peptides having n-terminal modifications |
| 01/02/1997 | EP0750620A1 Carbapenem compounds, compositions and methods of treatment |
| 01/02/1997 | EP0750618A1 Oxazolidinone derivatives and pharmaceutical compositions containing them |
| 01/02/1997 | EP0750611A1 Anilide derivatives as fungicides |
| 01/02/1997 | EP0750513A1 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
| 01/02/1997 | EP0750507A1 PROTEASOME REGULATION OF NF-$g(k)B ACTIVITY |
| 01/02/1997 | EP0750506A1 Broad spectrum antimicrobial compounds and methods of use |
| 01/02/1997 | EP0750457A1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells |
| 01/02/1997 | EP0607258B1 Use of ifn-gamma for the treatment of infections in transplant recipients |
| 01/02/1997 | EP0564461B1 The use of antibodies to tnf or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor |
| 01/02/1997 | EP0552178B1 Modified ribozymes |
| 01/02/1997 | EP0538341B1 Ehv-4 glycoprotein vaccine |
| 01/01/1997 | CN1139432A Prodrugs of inhibitor of HIV protease |
| 01/01/1997 | CN1139423A Method for colouring piece of rock by laser rays |
| 01/01/1997 | CN1139001A Antiphthitic medicine |
| 01/01/1997 | CN1138983A Preparation of drug composition |
| 01/01/1997 | CN1033701C Preparation of 9-(2-hydroxy-ethoxy-methyl) guanine derivative |
| 12/31/1996 | US5589594 Process for the preparation of cephem prodrug esters |
| 12/31/1996 | US5589510 Method for inhibiting retroviral infection by administering a naphthalenesulfonic acid compound |
| 12/31/1996 | US5589509 Enhancing effect of administered tumor cell-locating porphyrins in light irradiation to destroy tumor cells |
| 12/31/1996 | US5589484 Treatment of helicobacter infections, antiulcer |
| 12/31/1996 | US5589474 Dibenzothiazepinthione as antiviral agents |
| 12/31/1996 | US5589473 Mono- and bicyclic DNA gyrase inhibitors |
| 12/31/1996 | US5589384 Formation of pentamer complex and binding to gangliosides and hinges of glycineproline and antigens or epitopes |
| 12/31/1996 | US5589359 Chimeric proteins |
| 12/31/1996 | US5589341 Origin of replication complex genes and methods of using the same |
| 12/31/1996 | US5589175 Vaccines against aids |
| 12/31/1996 | CA2180280A1 Adenyl-cyclase-hemolysin (ac-hly)-protecting epitopes; use thereof for the treatment or the prevention of infections by bordetella |
| 12/27/1996 | WO1996041881A1 Type f botulinum toxin and use thereof |
| 12/27/1996 | WO1996041880A1 Adherence gene from helicobacter pylori and polypeptide coded thereby |
| 12/27/1996 | WO1996041874A1 Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection |
| 12/27/1996 | WO1996041807A1 Rapamycin derivatives |
| 12/27/1996 | WO1996041645A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
| 12/27/1996 | WO1996041643A1 Antiviral method and antiviral agent |
| 12/27/1996 | WO1996041639A1 Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells |
| 12/27/1996 | WO1996041626A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 12/27/1996 | WO1996041625A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| 12/27/1996 | WO1996041624A1 TNF-α CONVERTING ENZYME |
| 12/27/1996 | WO1996031607A3 Use of an 'immunodeficiency-virus suppressing lymphokine (isl)' to inhibit the replication of viruses, in particular of retroviruses |
| 12/27/1996 | WO1996021731A3 Stabilized external guide sequences |
| 12/27/1996 | EP0750037A2 TNF-convertase and method measuring inhibition of TNF convertase |
| 12/27/1996 | EP0749969A2 d4T polymorphic form I process |
| 12/27/1996 | EP0749752A1 Use of specific RXR receptor ligands |
| 12/27/1996 | EP0749487A1 Cell surface protein and effector cell bonding reagent |
| 12/27/1996 | EP0749485A1 ANTIMICROBIAL PROTEINS FROM $i(ARALIA) AND $i(IMPATIENS) |
| 12/27/1996 | EP0749484A1 COORDINATE $i(IN VIVO) GENE EXPRESSION |
| 12/27/1996 | EP0749452A1 Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents |
| 12/27/1996 | EP0749437A1 Steroid derivatives, pharmaceutical compositions containing them, and their pharmaceutical uses |